Active Stocks in Focus: ArQule Inc. (NASDAQ:ARQL), Genworth Financial, Inc. (NYSE:GNW), Turquoise Hill Resources Ltd. (NYSE:TRQ)

ArQule Inc. (NASDAQ:ARQL) Trend Analysis released that its optimistic top-line results from a randomized, double-blind, placebo-controlled Phase 2 clinical examination of tivantinib as a single agent in metastatic prostate cancer. In this test, 78 patients were randomized 2 to 1 to receive either tivantinib as a single agent or placebo. ArQule Inc. (NASDAQ:ARQL) stock hit highest price at $1.25, beginning with a price of $1.25 and reported an advance of 10.38% to the closed at $1.17 with a day range of $1.10-$1.25. The total market capitalization remained 73.4 Million, total volume of 2.1 Million shares held in the session was surprisingly higher than its average volume of 204.12 shares.Genworth Financial, Inc. (NYSE:GNW) Trend Analysis released that its previously revealed preliminary anticipates of the additional capital need to meet the PMIERs guidelines in their current form. The firm now estimate that the amount of additional capital required to meet these guidelines and operate business will be between $500 million and $700 million (Prior $450-550 mln) as of June 30, 2015. Genworth Financial, Inc. (NYSE:GNW) stock has highest price of $8.50 in last session, beginning with a price of $8.45 and reported a loss of -3.45% to the closed at $8.12 with a day range of $8.07-$8.50. The stock is going forward its 52-week low with 13.25% and moving down from its 52 week high price with -56.67%.Turquoise Hill Resources Ltd. (NYSE:TRQ) Trend Analysis released that its third quarter earnings of $0.02 a share, $0.01 better than the Capital IQ Consensus Estimate of $0.01; revenues rose year/year to $466 mln (from $15.65 mln) vs the $511.65 mln consensus. Shares of Turquoise Hill Resources Ltd. (NYSE:TRQ) traded at $3.25 by surging 2.20% with price volatility of 6.74% for a week and 5.07% for a month. Its beta stands at 1.89 times.